Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity

Launched by VANDERBILT UNIVERSITY MEDICAL CENTER · Sep 21, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on improving the way we diagnose a condition called Retinopathy of Prematurity (ROP), which affects some premature infants. The researchers are developing a new technology that helps doctors see and understand the blood vessels in the eyes of these babies more clearly. This could lead to better decisions about their care by finding important signs of ROP that current methods might miss.

To be eligible for this study, infants must be born between 24 and 34 weeks of pregnancy and weigh less than 1500 grams at birth. Unfortunately, babies who have already had surgery for ROP or who have other significant health issues that would make eye imaging unsafe cannot participate. If your baby qualifies, they will undergo noninvasive eye imaging to help gather important information about their eye health. The trial is currently not recruiting participants, but it aims to help improve the future care of infants with ROP.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Preterm male and female infants born at 24-34 weeks gestational age and weighing \<1500g at birth
• Exclusion Criteria:
• • Infants surgically treated for ROP
• • Infants with significant health concern that would preclude noninvasive retinal imaging as noted by the primary inpatient team